BioNTech (BNTX) is a publicly traded Healthcare sector company. As of October 3, 2026, BNTX trades at $97.25 with a market cap of $24.33B and a P/E ratio of 0.00. BNTX moved +0.08% today. Year to date, BNTX is +0.22%; over the trailing twelve months it is -7.28%. Its 52-week range spans $79.52 to $124.49. Analyst consensus is strong buy with an average price target of $126.85. Rallies surfaces BNTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks BNTX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $97.25 |
| Market Cap | $24.33B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 2.13% |
| 52-Week High | $124.49 |
| 52-Week Low | $79.52 |
| Volume | 627.13K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
14 analysts cover BNTX: 0 strong buy, 11 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $126.85.